Reacción #221013

ord-8e64dcc6990b40be99c8d84eb4c6fd47

Condiciones de reacción

Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    OtroThe solvent is removed in vacuo
  2. 2
    workup.ADDITIONDichloromethane is added to the residue
  3. 3
    Otroevaporated (this step
  4. 4
    Otroto give a white solid amino intermediate which
  5. 5
    OtroOrganic layer is separated
  6. 6
    ExtracciónThe aqueous layer is extracted twice with dichloromethane
  7. 7
    ExtracciónThe combined organic extracted
  8. 8
    Lavadoare washed with citric acid (4 ml), sodium carbonate (6 ml) and brine
  9. 9
    Secadodried over sodium sulfate
  10. 10
    Filtraciónfiltered
  11. 11
    Concentraciónconcentrated in vacuo
  12. 12
    Otrochromatographed with hexane/ethyl acetate from 5:1 to 1:1

Procedimiento

[4-(1-Ethoxymethyl-1H-imidazol-2-yl)-1-isopropyl-3-methyl-4-oxo-but-2-enyl]-methyl-carbamic acid tert-butyl ester (496 mg, 1.31 mmole) is stirred in 4N hydrochloric acid/dioxane at room temperature under nitrogen for 2 hours. The solvent is removed in vacuo. Dichloromethane is added to the residue and evaporated (this step is repeated twice) to give a white solid amino intermediate which then stirred with 2-tert-Butoxycarbonylamino-3,3-dimethyl-butyric acid (410.5 mg, 1.78 mmole), 3-(diethoxyphosphoryloxy)-1,2,3-benzotriazin-4(3H)-one (DEPBT, 531 mg, 1.77 mmole) and triethylamine (0.49 ml, 3.55 mmole) in 4 ml dichloromethane at room temperature overnight. The reaction mixture is diluted with dichloromethane/water. Organic layer is separated. The aqueous layer is extracted twice with dichloromethane. The combined organic extracted are washed with citric acid (4 ml), sodium carbonate (6 ml) and brine, dried over sodium sulfate, filtered, concentrated in vacuo. The residue is flash chromatographed with hexane/ethyl acetate from 5:1 to 1:1 to give a white crystals, (1-{[4-(-Ethoxymethyl-1H-imidazol-2-yl)-1-isopropyl-3-methyl-4-oxo-but-2-enyl]-methyl-carbonyl}-2,2-dimethyl-propyl)-carbamic acid tert-butyl ester: 171 mg (26%). MS(ES+): (M+H)=493.2

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US07390910B2uspto-grants-2008_06